Executive Leadership Committee
The Executive Leadership Committee is made up of individuals from various medical affairs backgrounds, whose mission it is to ensure the BCMAS program is always dynamic and innovative in accordance with the latest industry trends
Mena Boules
M.D
VP, Global Medical and Scientific Affairs at Ironwood Pharmaceuticals
Craig Granowitz
M.D, Ph.D
Chief Medical Officer at Lexicon Pharmaceuticals
Tracy Rockney
JD
Executive Vice President, Promotional Review & Labeling Services at ProPharma Group
Sam Rasty
PharmD, BCPS, MPH, BCMAS
Associate Director- Global Regulatory Affairs -US Advertising and Promotion at Eli Lilly & Company
Jill Massey
PharmD, MBA, BCMAS
Vice President, Global Medical Strategic Operations at Gilead Sciences
Tina Kanmaz
PharmD, BCMAS
Clinical Professor and Chair, Pharmacy Practice at St. John's University
Paul Korner
MD, MBA
Chief Medical Officer, Agile Therapeutics
Ike Ogbaa
MD, CMD
Vice President & Global Head of Medical Affairs
Elmar Orujov
MD, MBA, MPH, BCMAS
Director, Global Medical Affairs
Sameer Mistry
MD
Global Medical Affairs Lead - Early Drug Development, Immunology at GSK
Mairead Noone
MD
Medical Doctor, Pharmaceutical Leader
Merrell Lim
PharmD, BCMAS
Associate Regional Medical Director at AbbVie
Marianne Kenny
PharmD
Sr. Director, Scientific Communications and Operations
Luca Quagliata
PhD, BCMAS
Vice President, Global Head of Medical Affairs at Thermo Fisher Scientific
Janet Mastanduono
PhD RPh BCMAS
Medical Science Liaison Director at Novartis Pharmaceuticals
Ellis Wheby
PACS, CPPM
Associate Director, Field Reimbursement at Tarsus Pharmaceuticals, Inc
Julio J Fernandez
PharmD, RPh, MBA, BCMAS
Director, North America Strategic Engagement Medical Affairs at Regeneron
Steve Fields
Vice President - Field Access & Reimbursement at Inizio Engage
Imad Haddad
PharmD
Medical Communications and Content Solutions, Team Lead at Pfizer